Spyridon Karageorgos
-
- Antibiotic Use and Resistance 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Parasitology top 10%
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 5
- Infection Control in Healthcare 3
- Clinical Biochemistry top 10%
-
- Pneumonia and Respiratory Infections 5
-
- Antibiotics Pharmacokinetics and Efficacy 5
-
- Streptococcal Infections and Treatments 3
-
- Foreign Body Medical Cases 2
- Co-authors
- Constantinos TsioutisEleftherios MylonakisMichael MiligkosMarios DetsisEfthymia ProusaliMyrto Eleni FlokasMichail AlevizakosHamid Bassiri
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Frontiers in Immunology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- GreeceCyprusUnited States
In The Last Decade
Spyridon Karageorgos
26 papers receiving 419 citations
Peers
Comparison fields: 5 of 80
- Applied Microbiology and Biotechnology 53
- Molecular Medicine 73
- Parasitology 70
- Infectious Diseases 154
- Clinical Biochemistry 40
Countries citing papers authored by Spyridon Karageorgos
This map shows the geographic impact of Spyridon Karageorgos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyridon Karageorgos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyridon Karageorgos more than expected).
Fields of papers citing papers by Spyridon Karageorgos
This network shows the impact of papers produced by Spyridon Karageorgos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyridon Karageorgos. The network helps show where Spyridon Karageorgos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Spyridon Karageorgos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 0 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 22 | |
| 14 | 2017 | 6 | |
| 15 | 2017 | 50 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 45 | |
| 18 | 2016 | 15 | |
| 19 | 2016 | 83 | |
| 20 | 2015 | 8 |
About Spyridon Karageorgos
Spyridon Karageorgos is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 30 papers that have together received 427 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Pneumonia and Respiratory Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Use and Resistance (4 papers), Infection Control in Healthcare (3 papers), Streptococcal Infections and Treatments (3 papers) and Foreign Body Medical Cases (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Molecular Medicine (73 citations) and Parasitology (70 citations). Spyridon Karageorgos has collaborated with scholars based in Greece, Cyprus and United States. Frequent co-authors include Constantinos Tsioutis, Eleftherios Mylonakis, Michael Miligkos, Marios Detsis, Efthymia Prousali, Myrto Eleni Flokas, Michail Alevizakos, Hamid Bassiri, Fadi Shehadeh and Achilleas Gikas. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Immunology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.